![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, November 06, 2011 10:04:29 AM
2011 + $4.02
2012 + $1.72
2013 + $1.58
Assumptions
- No other gL enters the market place for 2012 & 2013.
- No $ contribution from other products (mC, FOB, etc...)
- Loss of market share to oral anticoagulant drugs is factored in to 2012 & 2013.
- MNTA's NOL's will largely get used up in 2011. MNTA will be fully taxed in 2012 and going forward......
Based on my interpretation of the agreement between MNTA/NVS apropos the "hybrid" royalty/profit share arrangement.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM